76 studies found for:    "quality of life" AND "HIV infections " [CONDITION ] | Open Studies
Show Display Options
Rank Status Study
21 Recruiting Randomized Trial of an HIV Navigation Program for Early Palliative Care
Conditions: HIV;   Chronic Disease
Intervention: Other: Patient Navigation
22 Recruiting A Sleep Program to Improve Sleep Quality in People With HIV
Conditions: HIV - Human Immunodeficiency Virus;   Insomnia Disorder
Intervention: Behavioral: Digital cognitive behavioural therapy for insomnia (dCBT-I)
23 Not yet recruiting Switching From Efavirenz/Atripla to Rilpivirine Among Patients With Neurocognitive or Neuropsychological Side Effects
Conditions: Impaired Cognition;   Depression/Anxiety;   Poor Quality Sleep;   Quality of Life;   HIV-1 Infection
Interventions: Drug: Immediate switch to TDF/FTC/RPV;   Drug: Switch to TDF/FTC/RPV after 12 weeks
24 Recruiting A Study to Investigate ALDOXORUBICIN in HIV-infected Subjects With Kaposi's Sarcoma
Conditions: Kaposi's Sarcoma;   HIV+;   HIV Positive;   AIDS
Intervention: Drug: aldoxorubicin
25 Not yet recruiting Bronchopulmonary Function in Response to Azithromycin Treatment for Chronic Lung Disease in HIV-infected Children
Conditions: Chronic Lung Disease;   HIV Infection
Interventions: Drug: Azithromycin;   Drug: Placebo
26 Not yet recruiting Prevalence, Characteristics and Risk Factors of HIV-Associated Neurocognitive Disorders in Subjects Between the Ages of 55 and 70 Years: An Exposed/Unexposed Cross Sectional Study
Condition: HIV-1 Infection
Interventions: Other: Health related quality of life and social and demographic informations;   Other: Neurocognitive assessment;   Radiation: cerebral images sub-study
27 Unknown  Research on Effect of Traditional Chinese Medicine (TCM) on Immune Reconstitution of HIV/AIDS Patients After Highly Active Antiretroviral Therapy (HAART)
Conditions: Acquired Immune Deficiency Syndrome Virus;   HIV Infections
Interventions: Drug: Fuzheng 2;   Drug: Placebo
28 Unknown  Clinical Trials on the Effect of Immunity 1 (Fuzheng 1) on Immune Reconstitution of HIV Patients
Conditions: Acquired Immune Deficiency Syndrome Virus;   HIV Infections
Interventions: Drug: Fuzheng 1;   Drug: Placebo
29 Recruiting CASA: Care and Support Access in HIV Disease
Condition: HIV/AIDS
Intervention: Other: CASA Education
30 Unknown  Once Daily 3TC, Efavirenz and ddI for HIV Infection
Conditions: HIV Infection;   AIDS
Intervention: Drug: once daily minimum 3-drug regimen of anti-retroviral medications
31 Recruiting Medication Adherence in Human Immunodeficiency Virus (HIV)
Condition: Human Immunodeficiency Virus
Interventions: Behavioral: Staff-delivered intervention sessions;   Other: Demographic Questionnaire;   Other: Questionnaires
32 Recruiting A Trial Evaluating Maintenance Therapy With Lamivudine (Epivir®) and Dolutegravir (Tivicay®) in Human Immunodeficiency Virus 1 (HIV-1) Infected Patients Virologically Suppressed With Triple Highly Active Antiretroviral Therapy (HAART) (ANRS 167 Lamidol)
Condition: HIV-1 Infection
Interventions: Drug: dolutegravir (Tivicay®) - Phase 1;   Drug: lamivudine (Epivir®) - Phase 2;   Drug: dolutegravir (Tivicay®) - Phase 2
33 Recruiting A Prospective Observational Trial to Determine Cardiovascular Diseases in HIV-infected Patients
Conditions: HIV-infection;   Coronary Heart Disease;   Myocardial Infarction;   HIV-encephalopathy;   Heart Failure;   Aging
Intervention: Other: Comprehensive non invasive cardiovascular examination
34 Not yet recruiting Feasibility, Tolerance and Efficacy of Interferon-free, Antiviral Treatment With Sofosbuvir and Ribavirin for the Treatment of Genotype 1, 2 and 4 Hepatitis C Virus-infected Patients in West and Central Africa
Conditions: Hepatitis C;   HIV Infection
Interventions: Drug: Sofosbuvir;   Drug: Ribavirin
35 Recruiting Impact of Immediate Versus South African Recommendations Guided ART Initiation on HIV Incidence
Condition: HIV Infection
Interventions: Drug: Immediate ARV treatment initiation with TDF/FTC/EFV;   Other: South African recommendation guided ARV (TDF/FTC/EFV) initiation
36 Unknown  Metabolic Safety of Raltegravir Versus Darunavir in HIV Naive Patients
Conditions: Cardiovascular Disease;   HIV Infections
37 Unknown  Buprenorphine and Integrated HIV Care Evaluation
Conditions: Opioid-Related Disorders;   HIV Infections;   AIDS
Interventions: Drug: Buprenorphine;   Behavioral: Integrated HIV care and office-based opioid dependence treatment
38 Unknown  BLADE: Comparison of Once Daily Lopinavir/Ritonavir to Lopinavir/Ritonavir BID Dosing in HIV-Infected Subjects
Condition: HIV Infections
39 Recruiting Switch to Darunavir/r + Maraviroc Quaque Die in Patients With R5 Tropism by Viral DNA Genotyping (GUSTA)
Condition: HIV Infection
Interventions: Drug: Maraviroc, Darunavir/r;   Drug: current antiretroviral therapy with 3 drugs
40 Not yet recruiting Hearts and Minds in HIV
Condition: HIV
Intervention: Behavioral: Let's Move Program

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years